{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:22:34Z","timestamp":1793773354272,"version":"4.6.1"},"reference-count":121,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Key Research and Development Project of China","award":["2023YFC2705804"],"award-info":[{"award-number":["2023YFC2705804"]}]},{"name":"Shenzhen Municipal fundings","award":["JCYJ20210324104204013, 20220815143953004"],"award-info":[{"award-number":["JCYJ20210324104204013, 20220815143953004"]}]},{"name":"Guangdong provincial medical scientific research fundings","award":["20221028195040676, A2023153"],"award-info":[{"award-number":["20221028195040676, A2023153"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173391, T2250610233; 82204882, H3302"],"award-info":[{"award-number":["82173391, T2250610233; 82204882, H3302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong provincial funding awards","award":["2021QN02Y112, 2023A1515010287"],"award-info":[{"award-number":["2021QN02Y112, 2023A1515010287"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjonc"],"accepted":{"date-parts":[[2024,7,4]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>Circulating tumour cells (CTCs) and CTC clusters are considered metastatic precursors due to their ability to seed distant metastasis. However, navigating the bloodstream presents a significant challenge for CTCs, as they must endure fluid shear forces and resist detachment-induced anoikis. Consequently, while a large number of cells from the primary tumour may enter the circulation, only a tiny fraction will result in metastasis. Nevertheless, the metastatic potency dramatically increases when CTCs travel in conjunction with other cell types to form CTC clusters, including neutrophils, myeloid-derived suppressor cells, macrophages, platelets, cancer-associated fibroblasts and red blood cells found in circulation. Such heterotypic CTC clustering events have been identified in a variety of cancer types and may serve as intriguing therapeutic targets and novel biomarkers for liquid biopsy. This review summarises recent advances in microfluidic technologies designed for the isolation of CTC clusters and explores the biological properties of distinct types of CTC clusters within the circulatory system. Investigation of the mechanisms of CTC cluster\u2013blood microenvironment interactions may offer a promising avenue for gaining fresh insights into CTC cluster-mediated metastatic progression and reveal potential opportunities for devising personalised antimetastasis treatments.<\/jats:p>","DOI":"10.1136\/bmjonc-2024-000437","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T23:20:17Z","timestamp":1726010417000},"page":"e000437","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Circulating tumour cell clusters: isolation, biological significance and therapeutic implications"],"prefix":"10.1136","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct01358903","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03785964","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01327846","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04942626","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03999749","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04673396","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02836600","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03422679","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03184870","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00942968","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yufan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhao","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Ye","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"},{"name":"Department of Dermatology, Shenzhen People's Hospital, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shenzhen People's Hospital, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Hu","sequence":"additional","affiliation":[{"name":"Shenzhen Key Laboratory of Biomimetic Robotics and Intelligent Systems, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9671-0116","authenticated-orcid":false,"given":"Xin","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Southern University of Science and Technology, Shenzhen, Guangdong, China"},{"name":"Key University Laboratory of Metabolism and Health of Guangdong, Southern University of Science and Technology, Shenzhen, Guangdong, China"},{"name":"Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Southern University of Science and Technology, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"2025090109100564000_3.1.e000437.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025090109100564000_3.1.e000437.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203543"},{"key":"2025090109100564000_3.1.e000437.3","first-page":"146","article-title":"A case of cancer in which cells similar to those in the tumours were seen in the blood after death","volume":"14","author":"Ashworth","year":"1869","journal-title":"Aust Med J"},{"key":"2025090109100564000_3.1.e000437.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.013"},{"key":"2025090109100564000_3.1.e000437.5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00044","article-title":"Computational and experimental models of cancer cell response to fluid shear stress","volume":"3","author":"Mitchell","year":"2013","journal-title":"Front Oncol"},{"key":"2025090109100564000_3.1.e000437.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.001"},{"key":"2025090109100564000_3.1.e000437.7","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res"},{"key":"2025090109100564000_3.1.e000437.8","first-page":"333","article-title":"Apoptosis: an early event in metastatic inefficiency","volume":"61","author":"Wong","year":"2001","journal-title":"Cancer Res"},{"key":"2025090109100564000_3.1.e000437.9","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1039\/D0LC00577K","article-title":"Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical applications","volume":"20","author":"Pei","year":"2020","journal-title":"Lab Chip"},{"key":"2025090109100564000_3.1.e000437.10","doi-asserted-by":"crossref","unstructured":"Descamps L , Le Roy D , Deman A-L . Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy. Int J Mol Sci 2022;23. doi:10.3390\/ijms23041981","DOI":"10.3390\/ijms23041981"},{"key":"2025090109100564000_3.1.e000437.11","doi-asserted-by":"crossref","first-page":"111298","DOI":"10.1016\/j.celrep.2022.111298","article-title":"Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance","volume":"40","author":"Pereira-Veiga","year":"2022","journal-title":"Cell Rep"},{"key":"2025090109100564000_3.1.e000437.12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10555-023-10124-z","article-title":"How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy","volume":"42","author":"Nasr","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"2025090109100564000_3.1.e000437.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1508541113"},{"key":"2025090109100564000_3.1.e000437.14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12628","article-title":"Selection and adaptation during metastatic cancer progression","volume":"501","author":"Klein","year":"2013","journal-title":"Nature New Biol"},{"key":"2025090109100564000_3.1.e000437.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813188106"},{"key":"2025090109100564000_3.1.e000437.16","doi-asserted-by":"crossref","unstructured":"Liu Z , Fusi A , Klopocki E , et al . Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med 2011;9. doi:10.1186\/1479-5876-9-70","DOI":"10.1186\/1479-5876-9-70"},{"key":"2025090109100564000_3.1.e000437.17","first-page":"427","article-title":"A new device for rapid isolation by size and characterization of rare circulating tumor cells","volume":"31","author":"Desitter","year":"2011","journal-title":"Anticancer Res"},{"key":"2025090109100564000_3.1.e000437.18","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2013.206805"},{"key":"2025090109100564000_3.1.e000437.19","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3404"},{"key":"2025090109100564000_3.1.e000437.20","doi-asserted-by":"crossref","unstructured":"Boya M , Ozkaya-Ahmadov T , Swain BE , et al . High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nat Commun 2022;13. doi:10.1038\/s41467-022-31009-9","DOI":"10.1038\/s41467-022-31009-9"},{"key":"2025090109100564000_3.1.e000437.21","doi-asserted-by":"crossref","unstructured":"Au SH , Edd J , Stoddard AE , et al . Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry. Sci Rep 2017;7. doi:10.1038\/s41598-017-01150-3","DOI":"10.1038\/s41598-017-01150-3"},{"key":"2025090109100564000_3.1.e000437.22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.7b00905"},{"key":"2025090109100564000_3.1.e000437.23","doi-asserted-by":"publisher","DOI":"10.1039\/C7LC00654C"},{"key":"2025090109100564000_3.1.e000437.24","doi-asserted-by":"crossref","unstructured":"Li D , Park Y , Hemati H , et al . Cell aggregation prevents anoikis and induces CD44 cleavage by maintaining lipid raft integrity to promote triple negative breast cancer metastasis. Res Sq 2023. doi:10.21203\/rs.3.rs-2535728\/v1","DOI":"10.21203\/rs.3.rs-2535728\/v1"},{"key":"2025090109100564000_3.1.e000437.25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0065"},{"key":"2025090109100564000_3.1.e000437.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524448113"},{"key":"2025090109100564000_3.1.e000437.27","doi-asserted-by":"crossref","unstructured":"Taftaf R , Liu X , Singh S , et al . ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun 2021;12. doi:10.1038\/s41467-021-25189-z","DOI":"10.1038\/s41467-021-25189-z"},{"key":"2025090109100564000_3.1.e000437.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.046"},{"key":"2025090109100564000_3.1.e000437.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108105","article-title":"Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells","volume":"32","author":"Donato","year":"2020","journal-title":"Cell Rep"},{"key":"2025090109100564000_3.1.e000437.30","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0875-0"},{"key":"2025090109100564000_3.1.e000437.31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature New Biol"},{"key":"2025090109100564000_3.1.e000437.32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature16140","article-title":"Neutrophils support lung colonization of metastasis-initiating breast cancer cells","volume":"528","author":"Wculek","year":"2015","journal-title":"Nature New Biol"},{"key":"2025090109100564000_3.1.e000437.33","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-3919"},{"key":"2025090109100564000_3.1.e000437.34","doi-asserted-by":"crossref","unstructured":"Lim M , Park S , Jeong H-O , et al . Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer. Cancers (Basel) 2021;13. doi:10.3390\/cancers13215272","DOI":"10.3390\/cancers13215272"},{"key":"2025090109100564000_3.1.e000437.35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10585-014-9660-7","article-title":"Living in shear: platelets protect cancer cells from shear induced damage","volume":"31","author":"Egan","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"2025090109100564000_3.1.e000437.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.01.001"},{"key":"2025090109100564000_3.1.e000437.37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1872"},{"key":"2025090109100564000_3.1.e000437.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009"},{"key":"2025090109100564000_3.1.e000437.39","doi-asserted-by":"crossref","unstructured":"Hapeman JD , Carneiro CS , Nedelcu AM . A model for the dissemination of circulating tumour cell clusters involving platelet recruitment and a plastic switch between cooperative and individual behaviours. BMC Ecol Evol 2023;23. doi:10.1186\/s12862-023-02147-5","DOI":"10.1186\/s12862-023-02147-5"},{"key":"2025090109100564000_3.1.e000437.40","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-916671"},{"key":"2025090109100564000_3.1.e000437.41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.7150\/ijbs.11589","article-title":"P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc Min\/+ Mice","volume":"11","author":"Qi","year":"2015","journal-title":"Int J Biol Sci"},{"key":"2025090109100564000_3.1.e000437.42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20657"},{"key":"2025090109100564000_3.1.e000437.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.092"},{"key":"2025090109100564000_3.1.e000437.44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.269811"},{"key":"2025090109100564000_3.1.e000437.45","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-4662"},{"key":"2025090109100564000_3.1.e000437.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164514","article-title":"The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"2025090109100564000_3.1.e000437.47","doi-asserted-by":"crossref","unstructured":"Cassetta L , Bruderek K , Skrzeczynska-Moncznik J , et al . Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation. J Immunother Cancer 2020;8. doi:10.1136\/jitc-2020-001223","DOI":"10.1136\/jitc-2020-001223"},{"key":"2025090109100564000_3.1.e000437.48","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.SABCS-4135"},{"key":"2025090109100564000_3.1.e000437.49","doi-asserted-by":"crossref","unstructured":"Sprouse ML , Welte T , Boral D , et al . PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS\/Notch\/Nodal Signaling. Int J Mol Sci 2019;20. doi:10.3390\/ijms20081916","DOI":"10.3390\/ijms20081916"},{"key":"2025090109100564000_3.1.e000437.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.03.016"},{"key":"2025090109100564000_3.1.e000437.51","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"2025090109100564000_3.1.e000437.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01267-2"},{"key":"2025090109100564000_3.1.e000437.53","doi-asserted-by":"crossref","first-page":"77124","DOI":"10.18632\/oncotarget.12808","article-title":"TGF-\u03b2 signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"2025090109100564000_3.1.e000437.54","doi-asserted-by":"crossref","unstructured":"Hamilton G , Rath B , Klameth L , et al . Small cell lung cancer: Recruitment of macrophages by circulating tumor cells. Oncoimmunology 2016;5. doi:10.1080\/2162402X.2015.1093277","DOI":"10.1080\/2162402X.2015.1093277"},{"key":"2025090109100564000_3.1.e000437.55","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"2025090109100564000_3.1.e000437.56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4226"},{"key":"2025090109100564000_3.1.e000437.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016234107"},{"key":"2025090109100564000_3.1.e000437.58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-021-06299-0","article-title":"Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis","volume":"189","author":"Sharma","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2025090109100564000_3.1.e000437.59","doi-asserted-by":"crossref","unstructured":"Hurtado P , Mart\u00ednez-Pena I , Yepes-Rodr\u00edguez S , et al . Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells. Front Cell Dev Biol 2023;11. doi:10.3389\/fcell.2023.1076432","DOI":"10.3389\/fcell.2023.1076432"},{"key":"2025090109100564000_3.1.e000437.60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4510"},{"key":"2025090109100564000_3.1.e000437.61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27510"},{"key":"2025090109100564000_3.1.e000437.62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74725"},{"key":"2025090109100564000_3.1.e000437.63","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3319"},{"key":"2025090109100564000_3.1.e000437.64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00985-8","article-title":"Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane","volume":"8","author":"Glentis","year":"2017","journal-title":"Nat Commun"},{"key":"2025090109100564000_3.1.e000437.65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2217\/bmm-2022-0409","article-title":"Pretreatment red blood cell distribution width may be a potential biomarker of prognosis in urologic cancer: a systematic review and meta-analysis","volume":"16","author":"Cao","year":"2022","journal-title":"Biomark Med"},{"key":"2025090109100564000_3.1.e000437.66","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.18632\/oncotarget.13784","article-title":"Prognostic value of RDW in cancers: a systematic review and meta-analysis","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"2025090109100564000_3.1.e000437.67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1354750X.2020.1731763","article-title":"Prognostic value of pre-treatment red blood cell distribution width in lung cancer: a meta-analysis","volume":"25","author":"Wang","year":"2020","journal-title":"Biomarkers"},{"key":"2025090109100564000_3.1.e000437.68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10237-016-0839-5","article-title":"Effects of flowing RBCs on adhesion of a circulating tumor cell in microvessels","volume":"16","author":"Xiao","year":"2017","journal-title":"Biomech Model Mechanobiol"},{"key":"2025090109100564000_3.1.e000437.69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13402-017-0317-9","article-title":"Tumor cells interact with red blood cells via galectin-4 - a short report","volume":"40","author":"Helwa","year":"2017","journal-title":"Cell Oncol"},{"key":"2025090109100564000_3.1.e000437.70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"2025090109100564000_3.1.e000437.71","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0351"},{"key":"2025090109100564000_3.1.e000437.72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/fon-2018-0295","article-title":"Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes","volume":"15","author":"Yang","year":"2019","journal-title":"Future Oncol"},{"key":"2025090109100564000_3.1.e000437.73","doi-asserted-by":"crossref","first-page":"80046","DOI":"10.18632\/oncotarget.11098","article-title":"First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors","volume":"7","author":"Menke-van der Houven van Oordt","year":"2016","journal-title":"Oncotarget"},{"key":"2025090109100564000_3.1.e000437.74","doi-asserted-by":"crossref","unstructured":"Jauw YWS , Huisman MC , Nayak TK , et al . Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody. EJNMMI Res 2018;8. doi:10.1186\/s13550-018-0358-8","DOI":"10.1186\/s13550-018-0358-8"},{"key":"2025090109100564000_3.1.e000437.75","doi-asserted-by":"crossref","unstructured":"Vona R , Iessi E , Matarrese P . Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity? Front Cell Dev Biol 2021;9. doi:10.3389\/fcell.2021.622908","DOI":"10.3389\/fcell.2021.622908"},{"key":"2025090109100564000_3.1.e000437.76","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1630-z"},{"key":"2025090109100564000_3.1.e000437.77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a \u03b3-Secretase Inhibitor for Desmoid Tumors","volume":"388","author":"Gounder","year":"2023","journal-title":"N Engl J Med"},{"key":"2025090109100564000_3.1.e000437.78","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/leu.2011.192","article-title":"MRK003, a \u03b3-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin\u2019s lymphoma","volume":"26","author":"Ramakrishnan","year":"2012","journal-title":"Leukemia"},{"key":"2025090109100564000_3.1.e000437.79","doi-asserted-by":"crossref","first-page":"S1435","DOI":"10.1016\/j.annonc.2022.08.075","article-title":"LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)","volume":"33","author":"Kasper","year":"2022","journal-title":"Ann Oncol"},{"key":"2025090109100564000_3.1.e000437.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.04.009"},{"key":"2025090109100564000_3.1.e000437.81","doi-asserted-by":"publisher","DOI":"10.1021\/jm000452m"},{"key":"2025090109100564000_3.1.e000437.82","doi-asserted-by":"crossref","unstructured":"Zhou J , Down JM , George CN , et al . Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis. Cancers (Basel) 2022;14. doi:10.3390\/cancers14194816","DOI":"10.3390\/cancers14194816"},{"key":"2025090109100564000_3.1.e000437.83","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"The Lancet"},{"key":"2025090109100564000_3.1.e000437.84","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-5597"},{"key":"2025090109100564000_3.1.e000437.85","first-page":"99","article-title":"ACO\/ARO\/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group","volume":"34","author":"Fleischmann","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025090109100564000_3.1.e000437.86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2291"},{"key":"2025090109100564000_3.1.e000437.87","doi-asserted-by":"crossref","unstructured":"Li JJ , Li SA , Daling JR , et al . Novel Small Molecule IL-6 Inhibitors as Anti-Cancer Drugs. Horm Carcinog III 2001. doi:10.1007\/978-1-4612-2092-3","DOI":"10.1007\/978-1-4612-2092-3"},{"key":"2025090109100564000_3.1.e000437.88","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23868"},{"key":"2025090109100564000_3.1.e000437.89","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/jcpt.13781","article-title":"Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential","volume":"47","author":"Ghasemi","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"2025090109100564000_3.1.e000437.90","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2904"},{"key":"2025090109100564000_3.1.e000437.91","doi-asserted-by":"crossref","unstructured":"Khan M , Arooj S , Wang H . NK Cell-Based Immune Checkpoint Inhibition. Front Immunol 2020;11. doi:10.3389\/fimmu.2020.00167","DOI":"10.3389\/fimmu.2020.00167"},{"key":"2025090109100564000_3.1.e000437.92","doi-asserted-by":"crossref","unstructured":"Wang X , Xiong H , Ning Z . Implications of NKG2A in immunity and immune-mediated diseases. Front Immunol 2022;13. doi:10.3389\/fimmu.2022.960852","DOI":"10.3389\/fimmu.2022.960852"},{"key":"2025090109100564000_3.1.e000437.93","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0298"},{"key":"2025090109100564000_3.1.e000437.94","doi-asserted-by":"crossref","unstructured":"Fisher JG , Doyle ADP , Graham LV , et al . Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer. Vaccines (Basel) 2022;10. doi:10.3390\/vaccines10121993","DOI":"10.3390\/vaccines10121993"},{"key":"2025090109100564000_3.1.e000437.95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/mab.2018.0043","article-title":"Enhancing Natural Killer and CD8+ T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8+ T Cells with HLA-E Monospecific Monoclonal Antibodies","volume":"38","author":"Ravindranath","year":"2019","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"2025090109100564000_3.1.e000437.96","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10620-022-07529-1","article-title":"Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression","volume":"68","author":"Wang","year":"2023","journal-title":"Dig Dis Sci"},{"key":"2025090109100564000_3.1.e000437.97","doi-asserted-by":"crossref","unstructured":"Cheng Y , Mo F , Li Q , et al . Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Mol Cancer 2021;20. doi:10.1186\/s12943-021-01355-1","DOI":"10.1186\/s12943-021-01355-1"},{"key":"2025090109100564000_3.1.e000437.98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073980","article-title":"Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition","volume":"23","author":"Korsten","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025090109100564000_3.1.e000437.99","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101092","article-title":"Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trial","volume":"32","author":"Clarke","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"2025090109100564000_3.1.e000437.100","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0709"},{"key":"2025090109100564000_3.1.e000437.101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021179","article-title":"Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1","volume":"24","author":"Sch\u00f6pe","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025090109100564000_3.1.e000437.102","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.7314\/APJCP.2012.13.9.4773","article-title":"Clinical study on safety and efficacy of Qinin\u00ae (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer","volume":"13","author":"Zhan","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"2025090109100564000_3.1.e000437.103","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10637-019-00739-x","article-title":"Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma","volume":"38","author":"Even","year":"2020","journal-title":"Invest New Drugs"},{"key":"2025090109100564000_3.1.e000437.104","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-023-00408-z","article-title":"Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment","volume":"12","author":"Bui","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"2025090109100564000_3.1.e000437.105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153957","article-title":"The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer","volume":"15","author":"Vigolo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025090109100564000_3.1.e000437.106","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1176"},{"key":"2025090109100564000_3.1.e000437.107","doi-asserted-by":"crossref","first-page":"34071","DOI":"10.18632\/oncotarget.6049","article-title":"Effects of a novel Nodal-targeting monoclonal antibody in melanoma","volume":"6","author":"Strizzi","year":"2015","journal-title":"Oncotarget"},{"key":"2025090109100564000_3.1.e000437.108","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0430-2"},{"key":"2025090109100564000_3.1.e000437.109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau9240","article-title":"Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies","volume":"11","author":"Panni","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025090109100564000_3.1.e000437.110","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603240"},{"key":"2025090109100564000_3.1.e000437.111","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025090109100564000_3.1.e000437.112","doi-asserted-by":"publisher","DOI":"10.1016\/S1877-1173(10)93014-7"},{"key":"2025090109100564000_3.1.e000437.113","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jth.12923","article-title":"Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study","volume":"13","author":"Francis","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2025090109100564000_3.1.e000437.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.06.028"},{"key":"2025090109100564000_3.1.e000437.115","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-322867"},{"key":"2025090109100564000_3.1.e000437.116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1278"},{"key":"2025090109100564000_3.1.e000437.117","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41418-020-0505-4","article-title":"Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA\/DLL4\/MMP13 axis","volume":"27","author":"Mancarella","year":"2020","journal-title":"Cell Death Differ"},{"key":"2025090109100564000_3.1.e000437.118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10637-020-01001-5","article-title":"A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors","volume":"39","author":"Doi","year":"2021","journal-title":"Invest New Drugs"},{"key":"2025090109100564000_3.1.e000437.119","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/2767-9764.CRC-23-0333","article-title":"A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors","volume":"3","author":"Hanna","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025090109100564000_3.1.e000437.120","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.120.000006"},{"key":"2025090109100564000_3.1.e000437.121","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2018-CT124","article-title":"Abstract CT124: A phase Ib\/II study of BMS-813160, a CC chemokine receptor (CCR) 2\/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with advanced pancreatic or colorectal cancer","volume":"78","author":"Le","year":"2018","journal-title":"Cancer Res"}],"container-title":["BMJ Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjonc-2024-000437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:10:23Z","timestamp":1756743023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjoncology.bmj.com\/lookup\/doi\/10.1136\/bmjonc-2024-000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,10]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjonc-2024-000437"],"URL":"https:\/\/doi.org\/10.1136\/bmjonc-2024-000437","relation":{},"ISSN":["2752-7948"],"issn-type":[{"value":"2752-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}